40
Participants
Start Date
September 30, 2008
Primary Completion Date
September 30, 2009
Study Completion Date
October 31, 2009
Armodafinil
Armodafinil once-daily (50 mg/day (1 tablet) on Day 1; increased to 100 mg/day (2 tablets) starting on Day 2; increased to 150 mg/day (3 tablets) starting on Day 5; increased to 200 mg/day (4 tablets) starting on Day 8). Then continue 200 mg/day dosage through Day 14.
Placebo
Matching Placebo dosed once-daily (50 mg/day (1 tablet) on Day 1; increased to 100 mg/day (2 tablets) starting on Day 2; increased to 150 mg/day (3 tablets) starting on Day 5; increased to 200 mg/day (4 tablets) starting on Day 8). Then continue 200 mg/day dosage through Day 14.
Beth Israel Deaconess Medical, Boston
Wake Research Associates, Raleigh
Duke University Medical Center, Durham
Washington University, St Louis
Pacific Research, San Diego
VA San Diego Healthcare System, San Diego
Peninsula Sleep Center, Burlingame
Stanford University, Stanford
Neurocare, Inc., Newton
Lead Sponsor
Cephalon
INDUSTRY